CoChat

Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt

Open access

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Background: Immunocompromised patients face reactivation of latent viruses that increase the risk of morbidity. Aim: The study aimed to detect human herpes virus 6 (HHV-6) reactivation among allogeneic (allo) and autologous (auto) hematopoietic stem cell transplant (HSCT) recipients and to correlate potentially attributed clinical manifestations to HHV-6 DNA plasma level. Methods: A prospective study included all (forty) patients undergoing allo and auto-HSCT from Jan 2020 till June 2022. Plasma samples were collected for HHV-6 serology, and for HHV-6 quantitative PCR at post-transplantation weeks 2, 4, 6. Demographic and clinical data were recorded. Results: Out of 40 peripheral blood stem cell transplant (PBSCT) recipients, 34 (85%) were HHV-6 IgG positive pre-HSCT. Of which, fourteen patients (14/34, 41.2%) showed positive HHV-6 DNaemia. HHV-6 DNAemia (15/40, 37.5%) was significantly higher among allo (8/12, 66.7%) versus auto (7/28, 25%) HSCT recipients (p = 0.030). Patients with HHV-6 DNAemia developed fever, delayed engraftment and bone marrow suppression in 6/15, 40%, thrombocytopenia (5/15, 33.3%), rash and pneumonitis (2/15, 13.3%), acute GVHD (aGVHD) (1/15, 6.7%). HHV-6 DNAemia ranged from 101 to 102,000 copies/mL. Univariate analysis identified conditioning with busulfan–cyclophosphamide as a significant risk (p = 0.043), while receiving BEAM protocol was a protective factor (p = 0.045). In multivariate analysis, receiving BEAM protocol retained significance (p = 0.040). Conclusion: Frequent HHV-6 reactivation was detected after HSCT, especially in allo-HSCT recipients with clinical manifestations which could not be otherwise explained. To our best knowledge this is the first study of HHV6 reactivation in HSCT recipients from Egypt. Raising awareness for HHV-6 reactivation manifestations and screening in HSCT recipients could be lifesaving.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12985-023-01980-w

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Cumulative incidence for first detection of HHV-6 DNAemia in plasma after HSCT using Kaplan–Meier curve
Fig. 1 Cumulative incidence for first detection of HHV-6 DNAemia in plasma after HSCT using Kaplan–Meier curveCC BY · PubMed Central
Fig. 2 The relation between the onset of HHV-6 DNAemia and viral load for patients positive for HHV-6 DNA (n = 15)
Fig. 2 The relation between the onset of HHV-6 DNAemia and viral load for patients positive for HHV-6 DNA (n = 15)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 3

  1. King O, Al Khalili Y. Herpes virus type 6. Treasure Island: StatPearls; 2020.
  2. IBM Corp Released. IBM SPSS statistics for Windows, Version 20.0. Armonk, NY: IBM Corp; 2011.
  3. Ouf NM, Abd M, Sattar EL, Sorady EL, Ghoneim FM, Moheb M, et al. Human cytomegalovirus in hematopoietic stem cell single experience. Senses Sci. 2022;9:1597–611.

Cited by

See all 9

Metadata

Authors
Raouf, M. M. E., Ouf, N. M., Elsorady, M. A. S., & Ghoneim, F. M.
Affiliations
Alexandria University (EG)
Corresponding author
Raouf, May Moheb Eldin
Venue
Virology Journal
Published
2023-02-04
Volume
20
Issue
1
Pages
20-20
ISSN
1743-422X (ISSN-L)
OpenAlex
W4319170656
Cited by
9
References
41
Citations by year
2026: 1 · 2025: 6 · 2024: 2
FWCI
1.79
Type
journal article
Language
en
Open access
Licence
Locations
  • Virology Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Alexandria University
Topics
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
  • Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
Keywords
human herpesvirus 6, HHV-6 reactivation, hematopoietic stem cell transplantation, allogeneic transplantation, autologous transplantation, immunocompromised patients, BEAM conditioning, busulfan and cyclophosphamide conditioning, graft-versus-host disease, delayed engraftment, thrombocytopenia
MeSH terms
Egypt, Humans, Prospective Studies, Herpesvirus 6, Human, Hematopoietic Stem Cell Transplantation, Roseolovirus Infections, Transplant Recipients

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt. https://app.cochat.ai/papers/10.1186/s12985-023-01980-w
The paper
Raouf, M. M. E., Ouf, N. M., Elsorady, M. A. S., & Ghoneim, F. M. (2023). Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt. Virology Journal. https://doi.org/10.1186/s12985-023-01980-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.